November 28, 2024

Novartis Announces 139 Layoffs in New Jersey Amid Ongoing Restructuring Efforts

5 months ago talkbio0Tagged Drug Industry, New Jersey, Novartis, restructuring

Novartis, layoffs, New Jersey, restructuring, pharmaceutical industry

Outlook Therapeutics to Resubmit BLA for ONS-5010 Despite Missing Primary Endpoint in NORSE EIGHT Trial

5 months ago talkbio0Tagged AMD, Approved, Attitude, Biologics License Application, Glycogen storage disease type II, Lytenava, New-onset refractory status epilepticus, United States Food and Drug Administration, Wet Age-Related Macular Degeneration

Outlook Therapeutics, ONS-5010, Lytenava, Wet Age-Related Macular Degeneration (wet AMD), Biologics License Application (BLA), NORSE EIGHT Trial, FDA Approval

Kronos Undergoes Major Restructuring: CEO Norbert Bischofberger Exits Amid 83% Workforce Reduction

5 months ago talkbio0Tagged Bischofberger, Industry, Kronos layoffs, Norbert, restructuring

Kronos layoffs, Norbert Bischofberger, biotech industry, workforce reduction, restructuring